ACI 3rd Annual Paragraph IV Disputes Conference

In its third year, ACI's conference on Paragraph IV Disputes is the ONLY event where both brand name and generic companies can come to hear insights from a top-notch faculty on every facet of Paragraph IV litigation, from pre-litigation concerns to the commencement of the suit to final adjudication – and every step in between.

With hundreds of billions of dollars in product sales currently subjected to Paragraph IV litigation, it is imperative that both brand and generic companies, and their counsel, have the offensive moves and defensive plays they respectively need in this high stakes arena of pharmaceutical patent endgame litigation.

In this high stakes and ruthless endgame, not a moment can be lost. Featuring preeminent patent litigators and in-house industry experts from both branded and generic companies, along with representatives from the FTC and preeminent judges, you cannot afford to miss this event.

Teresa Rea is the moderator on the session entitled "Positioning Your Patent/Product for Success at Trial: Crafting the Initial Pleadings, Seeking Declaratory Judgment and Managing the Markman Hearing.